Hartman Institute for Therapeutic Organ Regeneration

Generation of pluripotent stem cells from patients with type 1 diabetes.

TitleGeneration of pluripotent stem cells from patients with type 1 diabetes.
Publication TypeJournal Article
Year of Publication2009
AuthorsMaehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA
JournalProc Natl Acad Sci U S A
Volume106
Issue37
Pagination15768-73
Date Published2009 Sep 15
ISSN1091-6490
KeywordsAdult, Adult Stem Cells, Cell Dedifferentiation, Cell Differentiation, Cells, Cultured, Diabetes Mellitus, Type 1, Endoderm, Germ Layers, Humans, Kruppel-Like Factor 4, Male, Models, Biological, Pancreas, Pluripotent Stem Cells, Transcription Factors
Abstract

<p>Type 1 diabetes (T1D) is the result of an autoimmune destruction of pancreatic beta cells. The cellular and molecular defects that cause the disease remain unknown. Pluripotent cells generated from patients with T1D would be useful for disease modeling. We show here that induced pluripotent stem (iPS) cells can be generated from patients with T1D by reprogramming their adult fibroblasts with three transcription factors (OCT4, SOX2, KLF4). T1D-specific iPS cells, termed DiPS cells, have the hallmarks of pluripotency and can be differentiated into insulin-producing cells. These results are a step toward using DiPS cells in T1D disease modeling, as well as for cell replacement therapy.</p>

DOI10.1073/pnas.0906894106
Alternate JournalProc Natl Acad Sci U S A
PubMed ID19720998
PubMed Central IDPMC2735559
Grant ListR01 DK052431 / DK / NIDDK NIH HHS / United States
R01 DK066518 / DK / NIDDK NIH HHS / United States
/ HHMI / Howard Hughes Medical Institute / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065